Handelsavisen
prelaunch
Companies Utilities BIOEN.IS
BI
BIOEN.IS Borsa Istanbul Electric Utilities

Biotrend Cevre ve Enerji Yatirimlari AS

$19,00
Open in Charts → Attach watcher ⌖
TRY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
9,5B TRY
P/E
EV / Rev
Div yield
0,00 %
Op margin
-21,3 %
ROE
-49,6 %
Net margin
-47,0 %
Debt / equity
1,87
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Biotrend Cevre ve Enerji Yatirimlari AS is an independent power and renewable electricity producer operating in the utilities sector, generating revenue primarily through the production and sale of electricity.

Business. Biotrend Cevre ve Enerji Yatirimlari AS (BIOEN.IS) is a Turkish electric utility company engaged in the utilities sector. The firm is headquartered in Turkey and primarily listed on the Borsa Istanbul. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorUtilities
IndustryElectric Utilities
ActivityUtilities
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-49,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning BIOEN.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities · THIS SECTOR−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to BIOEN.IS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Peers
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated · Duke Energy (DUK)
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated · NextEra Energy (NEE)
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated · Southern Company (SO)
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Biotrend Cevre ve Enerji Yatirimlari AS (BIOEN.IS) is a Turkish electric utility company engaged in the utilities sector. The firm is headquartered in Turkey and primarily listed on the Borsa Istanbul. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorUtilities
    IndustryElectric Utilities
    ActivityUtilities
    AI synthesis
    GENERATED

    Biotrend Cevre ve Enerji Yatirimlari AS has a market capitalization of 8.53 billion TRY and a price-to-book ratio of 3.06, indicating that the market values the company at a premium to its book value. The company's liquidity position is characterized as medium risk, with a current ratio of 0.31, suggesting that it has limited short-term liquidity to cover its immediate liabilities. The company's cash and equivalents amount to 52.29 million TRY, which is significantly lower than its long-term debt of 5.21 billion TRY, resulting in a negative net cash position.

    The company's profitability is weak, with a net loss of 1.38 billion TRY and an operating loss of 627.47 million TRY in the latest reporting period. Its return on equity is -49.57%, and its return on assets is -14.28%, both of which are significantly below the industry median for Electric Utilities. The company's gross profit of 99.85 million TRY is insufficient to cover its operating expenses, contributing to the negative operating income.

    Biotrend Cevre ve Enerji Yatirimlari AS operates in a single business segment, and its geographic exposure is concentrated in Turkey, as disclosed in its financial statements. The company's revenue is entirely derived from this region, which may expose it to local economic and regulatory risks. There is no indication of revenue diversification across multiple geographic regions or business lines.

    The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the latest financial data. However, the company's capital expenditure of 578.75 million TRY indicates ongoing investment in its operations. The free cash flow is negative at -1.06 billion TRY, which may limit the company's ability to fund future growth initiatives without external financing.

    The company faces several risk factors, including a high debt-to-equity ratio of 1.87, which increases its financial leverage and exposes it to potential liquidity constraints. The risk assessment indicates a low probability of dilution, but the company's negative net cash position and high leverage could necessitate future equity or debt financing, which may lead to dilution. The company's operating cash flow of 701.99 million TRY provides some buffer against short-term obligations, but it is insufficient to cover the long-term debt.

    There are no recent events or filings disclosed in the latest data that would significantly impact the company's operations or financial position. The company's financial statements do not indicate any material changes in its business strategy or operational performance in the most recent reporting period.

    Key takeaways
    • Biotrend Cevre ve Enerji Yatirimlari AS is valued at a premium to book value, with a price-to-book ratio of 3.06.
    • The company is experiencing significant financial losses, with a net loss of 1.38 billion TRY and an operating loss of 627.47 million TRY.
    • The company's liquidity position is weak, with a current ratio of 0.31 and a negative net cash position.
    • The company's growth trajectory is uncertain, with no clear revenue growth projections and a negative free cash flow.
    • The company's high debt-to-equity ratio of 1.87 increases its financial leverage and exposes it to liquidity risks.
    • The company's operations are concentrated in Turkey, which may expose it to local economic and regulatory risks.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $19,00
    Market cap
    $8.53B
    Enterprise value
    $13.68B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    19.5x
    P / B
    3.1x
    P / Tangible book
    3.1x
    Tangible book
    $2.79B
    Net cash
    -$5.16B
    Current ratio
    0.3
    Debt / equity
    1.9
    ROA
    -14.3%
    ROE
    -49.6%
    Cash conversion
    -51.0%
    CapEx / revenue
    -19.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-21,3 %Bottom quartile
    Net Margin-47,0 %Bottom quartile
    ROE-49,6 %Bottom quartile
    Capex / Rev-19,7 %Below median
    D/E1,87Bottom quartile
    Cash Conv-0,51Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Biotrend Cevre ve Enerji Yatirimlari AS Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    BIOEN.ISCanonical
    Borsa Istanbul · TRY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    BIOENDUKNEESOElectric Utili
    This companyPeerSector

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage